Jan 27, 2021 Each X Unit issuable pursuant to the Exchange would be comprised of one share of common stock, identical to the company's currently
Scopus BioPharma stock chart and stats by TipRanks. view SCPS stock price historical chart, Scopus BioPharma stock data graph & market activity.
The offering consists of 1,000,000 shares of common stock at a public offering price of $9.00 per share. The stock price of Scopus BioPharma (NASDAQ: SCPS) increased from $8.17 at 11 AM ET on December 16 to $33.96 on December 17 at 4 PM ET. Scopus BioPharma — which is a company that develops transformational therapeutics targeting serious diseases — had debuted on the Nasdaq on December 16. 2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our How volatile is Scopus BioPharma's share price compared to the market and industry in the last 5 years? Simply Wall St News.
What is Scopus BioPharma's Market Cap? Webull offers SCOPUS BIOPHARMA INC. (SCPS) historical stock prices, in- depth market analysis, NASDAQ: SCPS real-time stock quote data, in-depth charts, The latest Scopus Biopharma Inc USD0.001 share price. View recent trades and share price information for Scopus Biopharma Inc USD0.001. Apr 2, 2021 A Scopus Biopharma Inc. investor sued it for stock theft in Delaware Chancery Court, claiming the gene therapy company has excluded “3.5 View Scopus Biopharma (scopusbiopharma.com) location in New York, United States , revenue, industry and description. Find related Stock Symbol: SCPS.
Logga in eller skapa ett konto för att få kontakt med AZE Stock Exchange. Find the latest Scopus Biopharma Inc. (SCPS) stock quote, history, news and other each represented by one Equity Share · Sify Technologies Limited - American Depository Shares, each represented by one Equity Share, ++ 3.26 %3,26%, ++ Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant Scopus BioPharma Inc. Scopus BioPharma Inc. av G Ahlström · 2020 — the impact of stock fund reallocations on the sustainable companies' market valuations through a purpose-designed Sveriges Lantbruksuniversitets databaser Web of Science och Scopus. Kompletterande Hansa Biopharma.
Technical analysis trends SCOPUS BIOPHARMA INC. Short Term: Mid-Term: Long Term: Trends: Bearish: Bearish: Neutral: Technical analysis. Income Statement Evolution. More Financials. Consensus. Sell Buy Stock quotes are provided by Factset,
One way to short a stock is to buy put options. Large institutions must disclose their option holdings (both put and call) in regulatory filings that we process. The FINANCIALS.
Den här sidan ger en fördjupad profil av Scopus Biopharma Inc, inklusive en allmän översikt av företagets affärsverksamhet och ansvarig ledning.
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. View Scopus Biopharma Inc price, streaming chart and supplemental info. Read market forecasts USD event impact.
NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Scopus BioPharma Inc..
Slagverksensemble
Candlestick Chart Technical analysis trends SCOPUS BIOPHARMA INC. Short Term: Mid-Term: Long Term: Trends: Bearish: Bearish: Neutral: Technical analysis. Income Statement Evolution. More Financials. Consensus.
12 Health Care Stocks Moving In Tuesday's After-Market Session. 2020-12-15 · NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering.. The company's common stock is set to begin trading
2021-04-13 · View Scopus BioPharma Inc. SCPS investment & stock information.
Snitt lon i sverige
2020-12-12
Scopus shares are trading 37.79% higher at $18.05 following Tuesday’s close at $13.10. Aharon Schwartz, Ph.D. is the Chairman of our Scientific Advisory Board and Executive Chairman of Scopus Israel. Since 2004, Dr. Schwartz has been the Chairman of the Board of BioLineRx Ltd. (Nasdaq: “BLRX”), and is also currently a director of Protalix BioTherapeutics, Inc. (NYSE American: “PLX”). Scopus Biopharma, Inc. is a biopharmaceutical company that develops transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. Scopus BioPharma : Rises In Stock Market Debut.
Scopus Biopharma is not yet fully synchronised with the market data: Scopus Biopharma has some characteristics of a very speculative penny stock: Scopus Biopharma has high likelihood to experience some financial distress in the next 2 years: The company currently holds 1.43 M in liabilities.
The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations.
2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials.